Atlas Trials

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Clinical trial NCT04902040 · TERMINATED

Trial details

NCT number
NCT04902040
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid NeoplasmAdvanced MelanomaAdvanced Merkel Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Merkel Cell Carcinoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Merkel Cell Carcinoma AJCC v8
Start date
2021-04-14
Primary completion
2025-02-27
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.